BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 11402322)

  • 21. Deletion mapping of 18q in conventional renal cell carcinoma.
    Hirata H; Matsuyama H; Matsumoto H; Korenaga Y; Ohmi C; Sakano S; Yoshihiro S; Naito K
    Cancer Genet Cytogenet; 2005 Dec; 163(2):101-5. PubMed ID: 16337851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The MXI1 tumor suppressor gene is not mutated in primary prostate cancer.
    Kuczyk MA; Serth J; Bokemeyer C; Schwede J; Herrmann R; Machtens S; Grünewald V; Höfner K; Jonas U
    Oncol Rep; 1998; 5(1):213-6. PubMed ID: 9458379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of heterozygosity on chromosome 2 in Japanese patients with prostate cancer.
    Ueda T; Komiya A; Suzuki H; Shimbo M; Sakamoto S; Imamoto T; Akakura K; Shiraishi T; Ichikawa T
    Prostate; 2005 Aug; 64(3):265-71. PubMed ID: 15717310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence that loss of chromosome 18q is associated with tumor progression.
    Frank CJ; McClatchey KD; Devaney KO; Carey TE
    Cancer Res; 1997 Mar; 57(5):824-7. PubMed ID: 9041179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of heterozygosity at 7q31.1 and 12p13-12 in advanced prostate cancer.
    Kawana Y; Ichikawa T; Suzuki H; Ueda T; Komiya A; Ichikawa Y; Furuya Y; Akakura K; Igarashi T; Ito H
    Prostate; 2002 Sep; 53(1):60-4. PubMed ID: 12210480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of heterozygosity of chromosome 8 microsatellite loci implicates a candidate tumor suppressor gene between the loci D8S87 and D8S133 in human prostate cancer.
    Trapman J; Sleddens HF; van der Weiden MM; Dinjens WN; Konig JJ; Schroder FH; Faber PW; Bosman FT
    Cancer Res; 1994 Dec; 54(23):6061-4. PubMed ID: 7954446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers.
    Thiagalingam S; Lengauer C; Leach FS; Schutte M; Hahn SA; Overhauser J; Willson JK; Markowitz S; Hamilton SR; Kern SE; Kinzler KW; Vogelstein B
    Nat Genet; 1996 Jul; 13(3):343-6. PubMed ID: 8673134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of heterozygosity at 7q31 is a frequent and early event in prostate cancer.
    Latil A; Cussenot O; Fournier G; Baron JC; Lidereau R
    Clin Cancer Res; 1995 Nov; 1(11):1385-9. PubMed ID: 9815935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An 800-kb region of deletion at 13q14 in human prostate and other carcinomas.
    Chen C; Frierson HF; Haggerty PF; Theodorescu D; Gregory CW; Dong JT
    Genomics; 2001 Oct; 77(3):135-44. PubMed ID: 11597138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Localization of potential tumor suppressor loci to a < 2 Mb region on chromosome 17q in human prostate cancer.
    Gao X; Zacharek A; Grignon DJ; Sakr W; Powell IJ; Porter AT; Honn KV
    Oncogene; 1995 Oct; 11(7):1241-7. PubMed ID: 7478543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a I-cM region of common deletion on 13q14 associated with human prostate cancer.
    Ueda T; Emi M; Suzuki H; Komiya A; Akakura K; Ichikawa T; Watanabe M; Shiraishi T; Masai M; Igarashi T; Ito H
    Genes Chromosomes Cancer; 1999 Mar; 24(3):183-90. PubMed ID: 10451697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allelic loss on chromosome 13q in human prostate carcinoma.
    Melamed J; Einhorn JM; Ittmann MM
    Clin Cancer Res; 1997 Oct; 3(10):1867-72. PubMed ID: 9815575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of heterozygosity at chromosome segment Xq25-26.1 in advanced human ovarian carcinomas.
    Choi C; Cho S; Horikawa I; Berchuck A; Wang N; Cedrone E; Jhung SW; Lee JB; Kerr J; Chenevix-Trench G; Kim S; Barrett JC; Koi M
    Genes Chromosomes Cancer; 1997 Nov; 20(3):234-42. PubMed ID: 9365830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of heterozygosity in human primary prostate carcinomas: a possible tumor suppressor gene at 7q31.1.
    Zenklusen JC; Thompson JC; Troncoso P; Kagan J; Conti CJ
    Cancer Res; 1994 Dec; 54(24):6370-3. PubMed ID: 7987830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DCC and SMAD4 alterations in human colorectal and pancreatic tumor dissemination.
    Tarafa G; Villanueva A; Farré L; Rodríguez J; Musulén E; Reyes G; Seminago R; Olmedo E; Paules AB; Peinado MA; Bachs O; Capellá G
    Oncogene; 2000 Jan; 19(4):546-55. PubMed ID: 10698524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SMAD4 as a prognostic marker in colorectal cancer.
    Alazzouzi H; Alhopuro P; Salovaara R; Sammalkorpi H; Järvinen H; Mecklin JP; Hemminki A; Schwartz S; Aaltonen LA; Arango D
    Clin Cancer Res; 2005 Apr; 11(7):2606-11. PubMed ID: 15814640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Deletion mapping of chromosome 18q and Smad proteins expression analysis in urinary bladder carcinomas].
    Fan Z; Zhang J; Bai J
    Zhonghua Zhong Liu Za Zhi; 2001 Mar; 23(2):135-7. PubMed ID: 11783019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A candidate tumor suppressor locus for scirrhous gastric cancer at chromosome 18q 12.2.
    Nishioka N; Yashiro M; Inoue T; Matsuoka T; Ohira M; Chung KH
    Int J Oncol; 2001 Feb; 18(2):317-22. PubMed ID: 11172598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer.
    Bova GS; Carter BS; Bussemakers MJ; Emi M; Fujiwara Y; Kyprianou N; Jacobs SC; Robinson JC; Epstein JI; Walsh PC
    Cancer Res; 1993 Sep; 53(17):3869-73. PubMed ID: 7689419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic and epigenetic alterations of BRG1 promote oral cancer development.
    Gunduz E; Gunduz M; Ouchida M; Nagatsuka H; Beder L; Tsujigiwa H; Fukushima K; Nishizaki K; Shimizu K; Nagai N
    Int J Oncol; 2005 Jan; 26(1):201-10. PubMed ID: 15586241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.